Recipharm AB

About Recipharm AB

Established in 1995, Recipharm’s manufacturing, fill & finish, and delivery-device services encompass a wide variety of drug dosage forms and modalities. Recipharm is an industry leading CDMO with over 30 facilities and 9,000 employees globally – supporting companies that are developing small molecules, biologics, and drug-device combinations. The company operates development and manufacturing facilities in France, Germany, India, Israel, Italy, Portugal, Spain, Sweden, the UK and the US. 

  • SE
  • 2015
    On CPHI since
  • 5000+
    Employees
Company types
Contract Service
Manufacturer/Innovator
Contact info
Meet us at

CPHI Japan 2024

East Halls 4, 5 & 6, Tokyo Big Sight, Tokyo, Japan
17 Apr 2024 – 19 Apr 2024

CPHI North America 2024

Pennsylvania Convention Center, Philadelphia
07 May 2024 - 09 May 2024

CPHI Milan 2024

Fiera Milano, Italy
08 Oct 2024 - 10 Oct 2024

Pharmapack Europe 2025

Paris Expo, Porte de Versailles - Hall 7.2 | Paris, France
22 Jan 2025 - 23 Jan 2025

Products from Recipharm AB (5)

  • Development & manufacture - drug delivery devices

    Product Development & manufacture - drug delivery devices

    Bespak by Recipharm delivers market leading design, development, and manufacturing services for drug delivery devices to the global pharmaceutical market. Our portfolio includes inhalers, nasal technologies, and auto-injectors as well as development and manufacturing services.
  • Drug Product

    Product Drug Product

    At Recipharm, we offer drug product development services for all common dosage forms. Our team can manage the complexity of your project, helping you find the best solution whether you are looking for development support to take your product to first-in-human (FIH) studies or to advance your product to mar...
  • Drug Substance

    Product Drug Substance

    Recipharm has more than 25 years’ experience in drug substance development and manufacturing. We are ideally placed to deliver a wide range of drug substance services from our dedicated development facilities around the world.
  • Integrated technology platform

    Product Integrated technology platform

    An integrated service for inhalation drug products and devices spanning early-stage development to commercial manufacture. Our depth of knowledge means we can overcome the challenges associated with inhalation drug products and devices.
  • Formulation Development

    Product Formulation Development

    Recipharm offer formulation development services for all dosage forms. We develop everything from simple formulations for early studies to more complex formulations suited for commercialisation.

Recipharm AB Resources (15)